{"symbol":"BMY","fiscalQuarter":"Q1-2021","reportDate":"2021-04-29","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2021","postBrief":{"headline":"Bristol Myers Squibb Misses on EPS \u2014 Stock Down 4.76%","keyNumbers":[{"metric":"EPS","actual":"$1.74","expected":"N/A","surprise":"-3.33%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing commitment to pipeline development.","They acknowledged competitive pressures in the market."],"summary":"Overall, management expressed a cautious optimism about future product launches while recognizing challenges in the current market landscape."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report shows a slight miss on EPS, which contributed to a notable decline in stock price. Investors may be concerned about the lack of guidance and the competitive pressures mentioned by management. The stock's drop of 4.76% reflects these uncertainties as the company navigates its future strategy.","metaDescription":"Bristol Myers Squibb (BMY) Q1 2021 earnings: EPS missed expectations. Stock down 4.76%. Full breakdown."}}